Quick Answer
PTC THERAPEUTICS, INC. reported Stockholders Equity of -$205.31 million for the year ending 2025.
- PTC THERAPEUTICS, INC. showed an increase of +81.3% in Stockholders Equity from 2024 to 2025.
- This data is from PTC THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $152.92 million | Q3 2013: $151.03 million | Q1 2014: $244.34 million | Q2 2014: $223.76 million | Q3 2014: $201.30 million | Q1 2015: $273.32 million | Q2 2015: $248.58 million | Q3 2015: $269.15 million | Q1 2016: $196.00 million | Q2 2016: $165.62 million | Q3 2016: $140.18 million | Q1 2017: $100.83 million | Q2 2017: $169.73 million | Q3 2017: $145.88 million | Q1 2018: $150.31 million | Q2 2018: $267.40 million | Q3 2018: $386.09 million | Q1 2019: $512.94 million | Q2 2019: $488.69 million | Q3 2019: $663.65 million | Q1 2020: $528.73 million | Q2 2020: $572.49 million | Q3 2020: $510.95 million | Q1 2021: $292.58 million | Q2 2021: $196.58 million | Q3 2021: $104.93 million | Q1 2022: -$90.58 million | Q2 2022: -$182.22 million | Q3 2022: -$226.90 million | Q1 2023: -$457.56 million | Q2 2023: -$579.27 million | Q3 2023: -$670.81 million | Q1 2024: -$893.92 million | Q2 2024: -$980.18 million | Q3 2024: -$1.05 billion | Q1 2025: -$185.76 million | Q2 2025: -$206.55 million | Q3 2025: -$155.76 million.
- Over the full 15 years of available data (2011 to 2025), PTC THERAPEUTICS, INC.'s Stockholders Equity has grown by 14.0%.
- Historical annual values: Fiscal year 2025: -$205.31 million | Fiscal year 2024: -$1.10 billion | Fiscal year 2023: -$818.56 million | Fiscal year 2022: -$347.09 million | Fiscal year 2021: $1.44 million | Fiscal year 2020: $481.98 million | Fiscal year 2019: $594.33 million | Fiscal year 2018: $350.73 million | Fiscal year 2017: $156.44 million | Fiscal year 2016: $119.58 million | Fiscal year 2015: $226.00 million | Fiscal year 2014: $298.47 million | Fiscal year 2013: $136.54 million | Fiscal year 2012: -$99.64 million | Fiscal year 2011: -$238.60 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: